Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS)

CNY 4.5

(-0.66%)

Net Debt Summary of Tianjin Tianyao Pharmaceuticals Co., Ltd.

  • Tianjin Tianyao Pharmaceuticals Co., Ltd.'s latest annual net debt in 2023 was 276.38 Million CNY , down -63.42% from previous year.
  • Tianjin Tianyao Pharmaceuticals Co., Ltd.'s latest quarterly net debt in 2024 Q2 was 33.62 Million CNY , down -83.3% from previous quarter.
  • Tianjin Tianyao Pharmaceuticals Co., Ltd. reported annual net debt of 755.56 Million CNY in 2022, down -35.71% from previous year.
  • Tianjin Tianyao Pharmaceuticals Co., Ltd. reported annual net debt of 1.17 Billion CNY in 2021, up 18.89% from previous year.
  • Tianjin Tianyao Pharmaceuticals Co., Ltd. reported quarterly net debt of 201.36 Million CNY for 2024 Q1, down -27.14% from previous quarter.
  • Tianjin Tianyao Pharmaceuticals Co., Ltd. reported quarterly net debt of -195.65 Million CNY for 2024 Q3, down -681.89% from previous quarter.

Annual Net Debt Chart of Tianjin Tianyao Pharmaceuticals Co., Ltd. (2023 - 1998)

Historical Annual Net Debt of Tianjin Tianyao Pharmaceuticals Co., Ltd. (2023 - 1998)

Year Net Debt Net Debt Growth
2023 276.38 Million CNY -63.42%
2022 755.56 Million CNY -35.71%
2021 1.17 Billion CNY 18.89%
2020 988.55 Million CNY 53.57%
2019 643.71 Million CNY 46.46%
2018 439.5 Million CNY 565.06%
2017 -94.5 Million CNY 48.72%
2016 -184.28 Million CNY -239.0%
2015 -54.36 Million CNY 63.28%
2014 -148.02 Million CNY -218.73%
2013 -46.44 Million CNY -114.75%
2012 314.81 Million CNY 34.9%
2011 233.37 Million CNY -70.04%
2010 778.96 Million CNY 61.87%
2009 481.24 Million CNY -27.23%
2008 661.3 Million CNY 38.28%
2007 478.22 Million CNY -27.89%
2006 663.15 Million CNY 19.8%
2005 553.56 Million CNY 131.01%
2004 239.62 Million CNY 52.46%
2003 157.17 Million CNY -54.31%
2002 343.97 Million CNY 2255.03%
2001 -15.96 Million CNY -107.54%
2000 211.73 Million CNY 3.41%
1999 204.75 Million CNY 41.0%
1998 145.21 Million CNY 0.0%

Peer Net Debt Comparison of Tianjin Tianyao Pharmaceuticals Co., Ltd.

Name Net Debt Net Debt Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. -6.15 Billion CNY 104.49%
Yabao Pharmaceutical Group Co., Ltd -408.64 Million CNY 167.636%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited -5.48 Billion CNY 105.043%
Harbin Pharmaceutical Group Co., Ltd. 498.52 Million CNY 44.559%
Tasly Pharmaceutical Group Co., Ltd -1.49 Billion CNY 118.534%
Zhejiang Medicine Co., Ltd. -658.58 Million CNY 141.967%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited -1.28 Billion CNY 121.503%
Lionco Pharmaceutical Group Co.,Ltd. 222.19 Million CNY -24.39%
Humanwell Healthcare (Group) Co.,Ltd. 5.84 Billion CNY 95.269%
Ginwa Enterprise (Group) Inc. -609.67 Million CNY 145.334%
Joincare Pharmaceutical Group Industry Co.,Ltd. -8.29 Billion CNY 103.334%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. -179.97 Million CNY 253.566%
China Animal Husbandry Industry Co., Ltd. -36.84 Million CNY 850.139%
Jiangsu Jibeier Pharmaceutical Co., Ltd. -684.96 Million CNY 140.351%
Zhejiang Huahai Pharmaceutical Co., Ltd. 6.1 Billion CNY 95.476%
Shanghai Haoyuan Chemexpress Co., Ltd. 598.96 Million CNY 53.856%
Ningbo Menovo Pharmaceutical Co., Ltd. 846.41 Million CNY 67.346%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd -2.47 Billion CNY 111.151%
Chongqing Taiji Industry(Group) Co.,Ltd 2.92 Billion CNY 90.554%
HPGC Renmintongtai Pharmaceutical Corporation 1.01 Billion CNY 72.871%
Nanjing Well Pharmaceutical Group Co.,Ltd. 329.41 Million CNY 16.097%
Henan Lingrui Pharmaceutical Co., Ltd. -1.34 Billion CNY 120.479%
Shenzhen Chipscreen Biosciences Co., Ltd. 828.33 Million CNY 66.634%
Guizhou Yibai Pharmaceutical Co., Ltd. 379.62 Million CNY 27.195%
Jiangsu Kanion Pharmaceutical Co.,Ltd. -1.92 Billion CNY 114.387%
Zhongzhu Healthcare Holding Co.,Ltd -330.03 Million CNY 183.744%
Beijing Tongrentang Co., Ltd -8.7 Billion CNY 103.175%
KPC Pharmaceuticals, Inc. -321.76 Million CNY 185.898%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. -1.17 Billion CNY 123.45%
North China Pharmaceutical Company Ltd. 10.74 Billion CNY 97.427%
China Resources Double-Crane Pharmaceutical Co.,Ltd. -2.75 Billion CNY 110.038%
Tibet Weixinkang Medicine Co., Ltd. -261.74 Million CNY 205.595%
China National Medicines Corporation Ltd. -7.76 Billion CNY 103.558%
Zhejiang Hisun Pharmaceutical Co., Ltd. 4.1 Billion CNY 93.268%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 1.69 Billion CNY 83.711%
ChengDu ShengNuo Biotec Co.,Ltd. 48.09 Million CNY -474.694%
Dali Pharmaceuticalco.,Ltd 9.46 Million CNY -2819.004%
Changchun BCHT Biotechnology Co. -421.7 Million CNY 165.54%
Zhejiang Shengda Bio-Pharm Co., Ltd. -85.28 Million CNY 424.09%
Shanghai Jiaoda Onlly Co.,Ltd 44.83 Million CNY -516.5%
Jiang Zhong Pharmaceutical Co.,Ltd -1.27 Billion CNY 121.655%
Mayinglong Pharmaceutical Group Co., LTD. -2.6 Billion CNY 110.599%
Cisen Pharmaceutical Co., Ltd. -812.71 Million CNY 134.008%
Hunan Warrant Pharmaceutical Co.,Ltd -355.46 Million CNY 177.754%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 25.97 Billion CNY 98.936%
Jianmin Pharmaceutical Group Co.,Ltd. 196.05 Million CNY -40.975%
Hunan Fangsheng Pharmaceutical Co., Ltd. 470.72 Million CNY 41.285%
Guangxi Wuzhou Zhongheng Group Co.,Ltd -1.17 Billion CNY 123.449%
Guobang Pharma Ltd. -1.13 Billion CNY 124.44%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 495.29 Million CNY 44.198%
Kangmei Pharmaceutical Co., Ltd. -801.59 Million CNY 134.48%
Shandong Buchang Pharmaceuticals Co., Ltd. 2.71 Billion CNY 89.82%
Zhejiang Starry Pharmaceutical Co.,Ltd. 2.62 Billion CNY 89.476%
Henan Taloph Pharmaceutical Stock Co.,Ltd 622.63 Million CNY 55.61%
ZhuZhou QianJin Pharmaceutical Co.,Ltd -1.88 Billion CNY 114.692%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 1.41 Billion CNY 80.48%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. -244.27 Million CNY 213.144%
Shanghai Shyndec Pharmaceutical Co., Ltd. -3.47 Billion CNY 107.954%
Shanghai Yizhong Pharmaceutical Co., Ltd. -870.73 Million CNY 131.742%
Tibet Rhodiola Pharmaceutical Holding Co. -184.66 Million CNY 249.67%
Sichuan Huiyu Pharmaceutical Co., Ltd. -1.34 Billion CNY 120.519%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 149.69 Million CNY -84.628%
CanSino Biologics Inc. 656.66 Million CNY 57.91%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 424.4 Million CNY 34.876%
Shandong Lukang Pharmaceutical Co.,Ltd. 2.63 Billion CNY 89.518%